Our venture companies receive the full backing of SPRIM. Working within the SPRIM family allows our investments to not only achieve funding, but leverage the global SPRIM organization to realize growth.
RheumaGen is a preclinical cell and gene therapy company developing cures for autoimmune diseases by attacking them at their source: the Human Leukocyte Antigen (HLA) gene.
STALICLA is a clinical-stage biopharmaceutical company with a team of domain experts, drug developers, clinicians, data scientists and computational biologists working to create NDD precision medicine solutions.
Doron Therapeutics strives to develop and deliver biotechnologies that help people get moving again.
Cilcare is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment.
The CoolStat is a completely new way to manage patient temperature.
Napo Therapeutics is an European pharmaceutical company, a young start-up led by a team of experienced professionals.
PulseSight’s mission is to develop life-changing solutions for patients with diseases leading to sight loss.
Inhalyx Biotech is engaged in the clinical development of Colistimethate Sodium (CMS), an inhaled macrocyclic therapeutic designed for the management of chronic infections associated with Cystic Fibrosis and non-CF Bronchiectasis.
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity.
Phoska Biopharma is a pre-clinical stage company advancing new breakthrough therapies in several indications.
Azalea Vision is a pioneering startup on the verge of revolutionizing eye care through our innovative smart contact lens technology.
Vaxxas is commercializing a novel vaccination technology that enhances the performance of existing and next-generation vaccines.
Seer is a medical technology company on a mission to give people more control of their most valuable assets—their health and their time—by reimagining how and where they undergo long-term clinical monitoring.
An Australian biotech company targeting treatment of immune system disorders with novel immunomodulatory drugs.
Neurocentrx is pioneering a safe, regulated oral ketamine therapy combining an abuse-deterrent capsule with digital prescription care to make rapid-acting depression treatment more accessible.
Lattice Medical develops innovative implants for reconstructive surgery, using their expertise in tissue engineering, biomaterials and 3D printing.
Fibronostics is a healthcare technology company focused on transforming non-invasive solutions for early disease intervention.
KAHR Bio is a clinical-stage biotechnology company developing innovative bi-specific fusion proteins, like DSP107, to harness the immune system for cancer therapy.
Priothera is a clinical-stage biopharmaceutical company focused on developing innovative immune modulators to improve outcomes for patients with hematological malignancies.
ErVimmune develops cancer vaccines and T cell-based therapies as breakthrough immunotherapies to address unmet medical needs in cold tumors.
EBT Medical is a clinical-stage company developing non-invasive neuromodulation technologies to reimagine the treatment of pelvic health disorders.
Travecta Therapeutics is developing a broad portfolio of product candidates engineered to cross the blood-brain-barrier.
ObvioHealth is a Virtual Research Organization (VRO) leading the long-overdue digitization of health innovation.
RegASK is a digital platform using natural language processing for answering regulatory questions about path-to-market and path-to-claims for product expansions into foreign markets.
SPRIM PRO is a global company that provides clinical trial and consumer health solutions in biopharmaceuticals and biotechnology, medical devices and digital therapeutics, and infant nutrition.
VCTC is a UK based patient centric clinical trial site that eliminates the burden of participation and facilitates the rapid recruitment of patients.
Hyfe AI detects and tracks cough in real-time, remotely and at scale.
1nHealth is a digital platform designed to accelerate the advancement of health through subject recruitment innovation, matching the right patients to the right trial at the right time.
Evid Science utilizes a well-developed cutting edge Artificial Intelligence to ensure their customers have timely access to the most up-to-date medical evidence.
Square 1 Labs is a full-service innovation accelerator, offering a suite of shared discovery services to help your company fast-track your early stage drug development.
